SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-19-000006
Filing Date
2019-09-03
Accepted
2019-09-03 07:02:33
Documents
34
Period of Report
2019-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brickell8-k.htm 8-K 169902
2 EXHIBIT 3.1 ex31certificateofincorpora.htm EX-3.1 9339
3 EXHIBIT 3.2 ex32amendmenttocertificate.htm EX-3.2 32390
4 EXHIBIT 3.3 ex33bylaws.htm EX-3.3 90521
5 EXHIBIT 3.4 ex34certificateofmerger.htm EX-3.4 13209
6 EXHIBIT 4.1 ex41formofwarrant.htm EX-4.1 60882
7 EXHIBIT 10.1 ex101fundingagreement.htm EX-10.1 371135
8 EXHIBIT 10.2 ex102licenseagreementkaken.htm EX-10.2 514533
9 EXHIBIT 10.3 ex103rightoffirstnegotiati.htm EX-10.3 97127
10 EXHIBIT 10.4 ex104bodorlicenseagreements.htm EX-10.4 159296
11 EXHIBIT 10.5 ex105uabrflicenseagreement.htm EX-10.5 265434
12 EXHIBIT 10.6 ex106-umlicenseagreement.htm EX-10.6 157000
13 EXHIBIT 10.7 ex107-licenseagreement.htm EX-10.7 467455
14 EXHIBIT 10.8 ex108assetpurchaseagreemen.htm EX-10.8 645376
15 EXHIBIT 10.9 ex109panmiraassetpurchasea.htm EX-10.9 252533
16 EXHIBIT 10.10 ex1010leaseandamendments.htm EX-10.10 244748
17 EXHIBIT 10.11 ex1011employmentagreementrb.htm EX-10.11 84484
18 EXHIBIT 10.12 ex1012employmentagreementas.htm EX-10.12 84773
19 EXHIBIT 10.13 ex1013employmentagreementdc.htm EX-10.13 132027
20 EXHIBIT 10.14 ex1014employmentagreementjb.htm EX-10.14 59542
21 EXHIBIT 10.15 ex1015employmentagreementdm.htm EX-10.15 126877
22 EXHIBIT 10.16 ex1016employmentagreemental.htm EX-10.16 80636
23 EXHIBIT 10.17 ex1017registrationrightsag.htm EX-10.17 121548
24 EXHIBIT 10.18 ex1018securityagreementred.htm EX-10.18 212642
25 EXHIBIT 23.1 ex231eyconsent.htm EX-23.1 12055
26 EXHIBIT 99.1 ex991pressrelease932019.htm EX-99.1 15225
27 EXHIBIT 99.2 ex992auditedfinancialstate.htm EX-99.2 583859
28 EXHIBIT 99.3 ex993unauditedinterimfinan.htm EX-99.3 583672
29 EXHIBIT 99.4 ex994unauditedproformacomb.htm EX-99.4 294365
30 ex991pressreleaselogo.gif GRAPHIC 68651
31 exhibit109redactedpan_image1.gif GRAPHIC 2624
32 exhibit109redactedpan_image2.jpg GRAPHIC 28591
33 exhibit1010executedle_image1.jpg GRAPHIC 383710
34 letterlogo.jpg GRAPHIC 4821
  Complete submission text file 0000819050-19-000006.txt   6617562
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 191070836
SIC: 2836 Biological Products, (No Diagnostic Substances)